<VariationArchive RecordType="classified" VariationID="403710" VariationName="NM_153240.5(NPHP3):c.3608del (p.Ala1203fs)" VariationType="Deletion" Accession="VCV000403710" Version="1" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2022-04-25" DateCreated="2017-04-16" MostRecentSubmission="2017-04-16">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="390680" VariationID="403710">
      <GeneList>
        <Gene Symbol="NPHP3-ACAD11" FullName="NPHP3-ACAD11 readthrough (NMD candidate)" GeneID="100532724" HGNC_ID="HGNC:48351" Source="calculated" RelationshipType="within multiple genes by overlap">
          <Location>
            <CytogeneticLocation>3q22.1</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="3" Accession="NC_000003.12" start="132558138" stop="132722459" display_start="132558138" display_stop="132722459" Strand="-" />
          </Location>
        </Gene>
        <Gene Symbol="NPHP3" FullName="nephrocystin 3" GeneID="27031" HGNC_ID="HGNC:7907" Source="submitted" RelationshipType="within multiple genes by overlap">
          <Location>
            <CytogeneticLocation>3q22.1</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="3" Accession="NC_000003.12" start="132680609" stop="132722409" display_start="132680609" display_stop="132722409" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="3" Accession="NC_000003.11" start="132399452" stop="132441302" display_start="132399452" display_stop="132441302" Strand="-" />
          </Location>
          <OMIM>608002</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_153240.5(NPHP3):c.3608del (p.Ala1203fs)</Name>
      <CanonicalSPDI>NC_000003.12:132683486:G:</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>3q22.1</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="3" Accession="NC_000003.12" start="132683487" stop="132683487" display_start="132683487" display_stop="132683487" variantLength="1" positionVCF="132683486" referenceAlleleVCF="AG" alternateAlleleVCF="A" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="3" Accession="NC_000003.11" start="132402331" stop="132402331" display_start="132402331" display_stop="132402331" variantLength="1" positionVCF="132402330" referenceAlleleVCF="AG" alternateAlleleVCF="A" />
      </Location>
      <ProteinChange>A1203fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000003.11" sequenceAccession="NC_000003" sequenceVersion="11" change="g.132402331del" Assembly="GRCh37">
            <Expression>NC_000003.11:g.132402331del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000003.12" sequenceAccession="NC_000003" sequenceVersion="12" change="g.132683487del" Assembly="GRCh38">
            <Expression>NC_000003.12:g.132683487del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_008130.1" sequenceAccession="NG_008130" sequenceVersion="1" change="g.43946del">
            <Expression>NG_008130.1:g.43946del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_008130.2" sequenceAccession="NG_008130" sequenceVersion="2" change="g.43946del">
            <Expression>NG_008130.2:g.43946del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="non-coding">
          <NucleotideExpression sequenceAccessionVersion="NR_037804.1" sequenceAccession="NR_037804" sequenceVersion="1" change="n.3614del">
            <Expression>NR_037804.1:n.3614del</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001619" Type="non-coding transcript variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_153240.5" sequenceAccession="NM_153240" sequenceVersion="5" change="c.3608del" MANESelect="true">
            <Expression>NM_153240.5:c.3608del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_694972.3" sequenceAccession="NP_694972" sequenceVersion="3" change="p.Ala1203fs">
            <Expression>NP_694972.3:p.Ala1203fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef ID="CA16609833" DB="ClinGen" />
        <XRef Type="rs" ID="1060499938" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_153240.5(NPHP3):c.3608del (p.Ala1203fs) AND Nephronophthisis 3" Accession="RCV000456125" Version="1">
        <ClassifiedConditionList TraitSetID="676">
          <ClassifiedCondition DB="MedGen" ID="C1858392">Nephronophthisis 3</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2017-04-11" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2017-04-11" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2017-04-16" MostRecentSubmission="2017-04-16">
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Description>Pathogenic</Description>
        <ConditionList>
          <TraitSet ID="676" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="5620" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Nephronophthisis 3</ElementValue>
                <XRef ID="72010" DB="GeneTests" />
                <XRef ID="MONDO:0011456" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Adolescent nephronophthisis</ElementValue>
                <XRef ID="Adolescent+nephronophthisis/7636" DB="Genetic Alliance" />
                <XRef ID="444749006" DB="SNOMED CT" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">NPH3</ElementValue>
                <XRef Type="MIM" ID="604387" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Preferred">NPHP3</ElementValue>
                <XRef Type="MIM" ID="604387" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">The nephronophthisis (NPH) phenotype is characterized by reduced renal concentrating ability, chronic tubulointerstitial nephritis, cystic renal disease, and progression to end-stage renal disease (ESRD) before age 30 years. Three age-based clinical subtypes are recognized: infantile, juvenile, and adolescent/adult. Infantile NPH can present in utero with oligohydramnios sequence (limb contractures, pulmonary hypoplasia, and facial dysmorphisms) or postnatally with renal manifestations that progress to ESRD before age 3 years. Juvenile NPH, the most prevalent subtype, typically presents with polydipsia and polyuria, growth retardation, chronic iron-resistant anemia, or other findings related to chronic kidney disease (CKD). Hypertension is typically absent due to salt wasting. ESRD develops at a median age of 13 years. Ultrasound findings are increased echogenicity, reduced corticomedullary differentiation, and renal cysts (in 50% of affected individuals). Histologic findings include tubulointerstitial fibrosis, thickened and disrupted tubular basement membrane, sporadic corticomedullary cysts, and normal or reduced kidney size. Adolescent/adult NPH is clinically similar to juvenile NPH, but ESRD develops at a median age of 19 years. Within a subtype, inter- and intrafamilial variability in rate of progression to ESRD is considerable. Approximately 80%-90% of individuals with the NPH phenotype have no extrarenal features (i.e., they have isolated NPH); ~10%-20% have extrarenal manifestations that constitute a recognizable syndrome (e.g., Joubert syndrome, Bardet-Biedl syndrome, Jeune syndrome and related skeletal disorders, Meckel-Gruber syndrome, Senior-LÃ¸ken syndrome, Leber congenital amaurosis, COACH syndrome, and oculomotor apraxia, Cogan type).</Attribute>
                <XRef ID="NBK368475" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">27336129</ID>
                <ID Source="BookShelf">NBK368475</ID>
              </Citation>
              <XRef ID="655" DB="Orphanet" />
              <XRef ID="C1858392" DB="MedGen" />
              <XRef ID="MONDO:0011456" DB="MONDO" />
              <XRef Type="MIM" ID="604387" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="1053823" SubmissionDate="2017-04-12" DateLastUpdated="2017-04-16" DateCreated="2017-04-16">
        <ClinVarSubmissionID localKey="A familial case of severe infantile nephronophthisis explained by oligogenic inheritance" submittedAssembly="GRCh37" title="A familial case of severe infantile nephronophthisis explained by oligogenic inheritance" />
        <ClinVarAccession Accession="SCV000540924" DateUpdated="2017-04-16" DateCreated="2017-04-16" Type="SCV" Version="1" SubmitterName="Molecular Medicine Center, Medical University of Sofia" OrgID="506095" OrganizationCategory="laboratory" OrgAbbreviation="MMC" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2017-04-11">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment Type="public">Affected child inherited 3 deleterious mutations in two nephronophthisis genes, NPHP3 and NPHP4. Possibility for epistatic interaction of the NPHP mutations.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="ModeOfInheritance">Autosomal recessive inheritance</Attribute>
        </AttributeSet>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Submitter's publication</Attribute>
          <Citation Type="general">
            <ID Source="DOI">10.1016/j.ejmg.2017.04.002</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>paternal</Origin>
              <Ethnicity>Caucasian</Ethnicity>
              <GeographicOrigin>Bulgaria</GeographicOrigin>
              <Species TaxonomyId="9606">human</Species>
              <Age Type="minimum" age_unit="years">0</Age>
              <Age Type="maximum" age_unit="years">9</Age>
              <AffectedStatus>yes</AffectedStatus>
              <Gender>male</Gender>
            </Sample>
            <Method>
              <NamePlatform>MiSeq</NamePlatform>
              <TypePlatform>Next-generation exome sequencing</TypePlatform>
              <Description>Sequencing by synthesis</Description>
              <MethodType>clinical testing</MethodType>
              <MethodAttribute>
                <Attribute Type="StructVarMethodType">Sequence alignment</Attribute>
              </MethodAttribute>
              <MethodAttribute>
                <Attribute Type="TestName">TruSight One</Attribute>
              </MethodAttribute>
            </Method>
            <ObservedData>
              <Attribute Type="CompoundHeterozygote" integerValue="1" />
            </ObservedData>
            <TraitSet Type="Finding">
              <Trait Type="Finding" ClinicalFeaturesAffectedStatus="present">
                <XRef DB="Human Phenotype Ontology" ID="HP:0000090" />
              </Trait>
            </TraitSet>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="NPHP3">
              <Name>nephrocystin 3</Name>
            </Gene>
          </GeneList>
          <VariantType>Variation</VariantType>
          <Location>
            <GeneLocation>NM_153240.4:exon 25</GeneLocation>
          </Location>
          <AttributeSet>
            <Attribute Type="HGVS">NM_153240.4:c.3608delC</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="604387" />
          </Trait>
        </TraitSet>
        <Citation Type="general">
          <ID Source="DOI">10.1016/j.ejmg.2017.04.002</ID>
        </Citation>
        <SubmissionNameList>
          <SubmissionName>A familial case of severe infantile nephronophthisis e</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="1053823" TraitType="Finding" MappingType="XRef" MappingValue="HP:0000090" MappingRef="Human Phenotype Ontology">
        <MedGen CUI="C0687120" Name="Nephronophthisis" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1053823" TraitType="Disease" MappingType="XRef" MappingValue="604387" MappingRef="OMIM">
        <MedGen CUI="C1858392" Name="Nephronophthisis 3" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

